Table 2:

Probability of Falls

	Number of at-risk patients	Cases of Incident Falls	Cases of injurious falls	Probability of Falls at 1 year* (Standard Deviation)	Probability of Injurious falls at 1 year* (Standard Deviation)	Probability of Falls at 3 year3 * (Standard Deviation)	Probability of Injurious falls at 3 years* (Standard Deviation)
Overall	299	141	38	28.8 ± 2.6%	9.1 ± 1.7%	50.2 ± 3.1%	16.5 ± 2.7%
Child A	209	93	27	28.4 ± 3.1%	8.9 ± 3.2%	46.8 ± 3.7%	16.2 ± 3.2%
Child B	90	48	11	30.0 ± 4.9%	9.2 ± 2.1%	57.8 ± 5.7%	17.2 ± 5.3%
Ascites	122	63	18	31.3 ± 4.2%	12.8 ± 3.2%	55.7 ± 4.9%	18.7 ± 4.3%
Paracentesis	30	15	4	36.7 ± 9.0%	11.4 ± 6.3%	50.8 ± 9.6%	18.9 ± 9.6%
No Ascites	177	78	20	27.2 ± 3.4%	6.6 ± 1.9%	46.3 ± 4.0%	14.9 ± 3.5%
Age ≥ 60 years	158	81	25	30.5 ± 3.7%	11.8 ± 2.7%	55.4 ± 4.4%	19.5 ± 3.9%
Age <60 years	141	60	13	27.0 ± 3.8%	6.0 ± 3.6%	44.7 ± 4.4%	12.8 ± 3.6%
Weighted Lures >24	91	45	9	29.8 ± 4.8%	7.3 ± 2.9%	53.0 ± 5.7%	14.0 ± 4.8%
Weighted Lures ≤ 24	170	73	18	26.5 ± 4.2%	7.1 ± 3.5%	46.1 ± 4.2%	14.1 ± 3.5%
Alcohol-related liver disease	65	34	15	30.8 ± 5.8%	14.6 ± 4.6%	56.4 ± 6.7%	28.7 ± 4.6%
Alcohol abuse	21	10	5	14.3 ± 7.8%	5.0 ± 5.0%	47.6 ± 11.4%	26.6 ± 10.7%
Non-alcoholic fatty liver	99	57	11	40.4 ± 5.0%	11.0 ± 3.5%	59.0 ± 5.3%	12.8 ± 3.9%
Prior falls	65	52	16	63.1 ± 6.1%	25.7 ± 6.1%	83.7 ± 5.2%	39.5 ± 6.1%
No prior falls	234	89	22	19.3 ± 2.6%	5.1 ± 1.5%	41.0 ± 3.5%	11.9 ± 2.6%
Any disability	26	18	4	53.8 ± 10.1%	20.2 ± 9.6	75.9 ± 11.3%	20.2 ± 9.6%
No disability	273	123	34	26.5 ± 2.7%	8.2 ± 1.7%	48.0 ± 3.2%	16.0 ± 2.8%
Benzodiazepine user	55	36	8	41.9 ± 6.7%	14.5 ± 5.2%	70.7 ± 7.1%	17.4 ± 5.9%
Benzodiazepine nonuser	244	105	30	25.9 ± 2.8%	8.0 ± 1.8%	45.7 ± 3.4%	15.8 ± 2.9%
Opioid user	66	41	14	41.9 ± 6.7%	18.0 ± 5.0%	64.0 ± 6.3%	18.0 ± 7.2%
Opioid nonuser	233	100	24	25.9 ± 2.8%	6.6 ± 1.7%	46.2 ± 3.5%	13.4 ± 2.8%
Beta-blocker user	120	58	15	27.7 ± 4.1%	7.2 ± 2.5%	52.3 ± 5.1%	17.8 ± 4.9%
Beta-blocker non-user	179	83	23	29.6 ± 3.4%	10.4 ± 2.4%	48.9 ± 4.0%	15.9 ± 3.2%

^*competing risk analysis.